Multiple myeloma Journal Article
| Authors: | Anderson, K. C.; Alsina, M.; Bensinger, W.; Biermann, J. S.; Chanan-Khan, A.; Cohen, A. D.; Devine, S.; Djulbegovic, B.; Gasparetto, C.; Huff, C. A.; Jagasia, M.; Medeiros, B. C.; Meredith, R.; Raje, N.; Schriber, J.; Singhal, S.; Somlo, G.; Stockerl-Goldstein, K.; Tricot, G.; Vose, J. M.; Weber, D.; Yahalom, J.; Yunus, F. |
| Article Title: | Multiple myeloma |
| Abstract: | Although MM is sensitive to both chemotherapy and radiation therapy, it remains incurable. However, treatment algorithms (based on published data and clinical experience) can be developed to optimize therapy, which include not only therapy for the underlying disease but also supportive therapy to enhance quality of life. Because myeloma is incurable, these guidelines prominently identify the clinical settings appropriate for treating patients enrolled in clinical research protocols. © Journal of the National Comprehensive Cancer Network. |
| Keywords: | cancer survival; treatment response; survival rate; overall survival; fludarabine; lenalidomide; prednisone; thalidomide; clinical trial; neutropenia; review; cisplatin; doxorubicin; interferon; cancer combination chemotherapy; unspecified side effect; cancer adjuvant therapy; cancer radiotherapy; radiation dose; rituximab; cancer staging; drug megadose; nuclear magnetic resonance imaging; antineoplastic agent; cancer diagnosis; cancer palliative therapy; unindexed drug; progression free survival; quality of life; bortezomib; proteasome inhibitor; computer assisted tomography; drug eruption; multiple myeloma; erythropoietin; anemia; etoposide; neuropathy; thrombocytopenia; antineoplastic combined chemotherapy protocols; peripheral neuropathy; bisphosphonates; c-reactive protein; combination chemotherapy; cytogenetics; immunomodulatory drugs; nccn clinical practice guidelines; novel therapies; primary amyloidosis; stem cell transplant; supportive therapies; waldenström's monoclonal protein; aciclovir; alkylating agent; antifungal agent; bendamustine; bisphosphonic acid derivative; calcitonin; calcium; creatinine; cyclophosphamide; dexamethasone; furosemide; hemoglobin; immunoglobulin; melphalan; nucleoside analog; pneumococcus vaccine; steroid; vincristine; allogenic bone marrow transplantation; amyloidosis; anticoagulant therapy; autologous stem cell transplantation; bone pain; bradycardia; calcium blood level; cancer pain; clinical protocol; creatinine blood level; deep vein thrombosis; diagnostic approach route; hemoglobin blood level; herpes simplex; herpes zoster; hypercalcemia; hyperviscosity syndrome; influenza vaccination; kidney failure; light chain; patient assessment; patient monitoring; plasmacytoma; plasmapheresis; pneumocystis pneumonia; practice guideline; recurrent infection; stem cell transplantation; tumor biopsy; urea nitrogen blood level; waldenstroem macroglobulinemia; hematopoietic stem cell transplantation |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 7 |
| Issue: | 9 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2009-10-01 |
| Start Page: | 908 |
| End Page: | 942 |
| Language: | English |
| PUBMED: | 19878637 |
| PROVIDER: | scopus |
| DOI: | 10.6004/jnccn.2009.0061 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 30 November 2010" - "Source: Scopus" |
